ORIC Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update Portfolio News / Karina Tin August 11, 2022 ORIC Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update Read More »
RAPT Therapeutics Reports Second Quarter 2022 Financial Results Portfolio News / Karina Tin August 11, 2022 RAPT Therapeutics Reports Second Quarter 2022 Financial Results Read More »
Surrozen Reports Second Quarter 2022 Financial Results Portfolio News / Karina Tin August 11, 2022 Surrozen Reports Second Quarter 2022 Financial Results Read More »
Tenaya Therapeutics Reports Second Quarter 2022 Financial Results & Provides Business Update Portfolio News / Karina Tin August 10, 2022 Tenaya Therapeutics Reports Second Quarter 2022 Financial Results & Provides Business Update Read More »
eFFECTOR Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update Portfolio News / Karina Tin August 9, 2022 eFFECTOR Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update Read More »
eFFECTOR Therapeutics Appoints Douglas Warner, M.D., as Chief Medical Officer Portfolio News / Karina Tin August 8, 2022 eFFECTOR Therapeutics Appoints Douglas Warner, M.D., as Chief Medical Officer Read More »
Kallyope’s Newly Established Clinical Development Advisory Board Joined By Renowned Biopharma Leaders Portfolio News / Karina Tin August 5, 2022 Kallyope’s Newly Established Clinical Development Advisory Board Joined By Renowned Biopharma Leaders Read More »
NGM Bio Provides Business Highlights and Reports Second Quarter 2022 Financial Results Portfolio News / Karina Tin August 4, 2022 NGM Bio Provides Business Highlights and Reports Second Quarter 2022 Financial Results Read More »
Nurix Therapeutics Announces Appointment of Eric Schlezinger, J.D. as Chief People Officer Portfolio News / Karina Tin August 3, 2022 Nurix Therapeutics Announces Appointment of Eric Schlezinger, J.D. as Chief People Officer Read More »
